Form 4 holding
Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 66,849
- Estimated value
- $15,242
- Report date
- 01 Jan 2025
- Price
- $0.2280
- Ownership
- Direct
Ibrahim B. Dagher - Director at BRAINSTORM CELL THERAPEUTICS INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BCLI on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Ibrahim B. Dagher since 02 Aug 2025
Reported holdings for Ibrahim B. Dagher in BRAINSTORM CELL THERAPEUTICS INC.
Form 4 holding
Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 10,666
- Estimated value
- $2,432
- Report date
- 01 Jan 2025
- Price
- $0.2280
- Ownership
- By the Reporting Person's Roth IRA
Form 4 holding
Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Common Stock
- Shares / value
- 2,000
- Estimated value
- $456
- Report date
- 01 Jan 2025
- Price
- $0.2280
- Ownership
- Indirect
Form 4 holding
Director
BRAINSTORM CELL THERAPEUTICS INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 225,000
- Estimated value
- Report date
- 26 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Ibrahim B. Dagher in BRAINSTORM CELL THERAPEUTICS INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.